Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review

Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-stage solid tumors. However, its success has been far more limited in hematological malignancies and is mostly restricted to classical Hodgkin lymphoma (cHL) and primary mediastinal B cell lymphoma (PMBCL). In pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdikis-Prati, Sarah, Sheikh, Semira, Bouroumeau, Antonin, Lang, Noémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296250/
https://www.ncbi.nlm.nih.gov/pubmed/37371815
http://dx.doi.org/10.3390/biomedicines11061720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296250/
https://www.ncbi.nlm.nih.gov/pubmed/37371815
http://dx.doi.org/10.3390/biomedicines11061720

Ejemplares similares